
|Articles|July 25, 2013
Session 1: Discussant
Author(s)William H. Herman, MD, MPH
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective.
Advertisement
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective. "There is no one-size-fits-all measure of diabetes quality or glycemic care," said Dr Herman. Dr Herman also discussed his viewpoint as a clinical endocrinologist diabetologist. "So patients who are remarkably likely to have targets I think the targets were appropriately modified based on risk of hypoglycemia," said Herman. "I do have general concern that maybe the targets are even too low based on the evidence."
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
2
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
3
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
4
Cleveland Panel Weighs New HFpEF Pathway, Access to Finerenone
5




